person · Reporting owner

LIVERIS ANDREW N

Disclosed activity across 5 companies

Tapewire entity: 14463
SEC CIK: 0001269971

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CITIGROUP INCC · Entity 2837	Director	January 18, 2011	January 20, 2011
DuPont de Nemours, Inc.DWDP · Entity 3297	Former Executive Chairman	June 11, 2018	June 13, 2018
INTERNATIONAL BUSINESS MACHINES CORPIBM · Entity 2840	Director	September 30, 2026	October 02, 2026
Lucid Group, Inc.LCID · Entity 1530	Director	June 04, 2026	June 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CITIGROUP INC

Report date January 18, 2011 · Filed January 20, 2011

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	106,923.7	Reported balance After 2011-01-18 transaction · row 1 1 source row Row 1 · 2011-01-18 · Grant · Acquired 29,880.4 · Balance 106,923.7 F1: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	3,828.7	Reported balance Holding disclosure · report date 2011-01-18 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 3,828.7 F2: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors.
Common StockSEC Table I · non-derivative	IndirectBy Children	1,200	Reported balance Holding disclosure · report date 2011-01-18 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 1,200

Filing footnotes · ownership attribution and instrument terms

F1: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors.

F2: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors.

DuPont de Nemours, Inc.

Report date June 11, 2018 · Filed June 13, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	387,618.089	Ending reported balance After 2018-06-12 transaction · row 4 4 source rows · reconciled sequence Row 1 · 2018-06-11 · Exercise / conversion · Acquired 73,902 · Balance 461,520.089 Row 2 · 2018-06-11 · Sale · Disposed 73,902 · Balance 387,618.089 F1: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.60. Row 3 · 2018-06-12 · Exercise / conversion · Acquired 26,098 · Balance 413,716.089 Row 4 · 2018-06-12 · Sale · Disposed 26,098 · Balance 387,618.089 F1: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.65.
Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.53 · Expires 2019-02-13	Direct	366,792	Reported balance After 2018-06-11 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2018-06-11 · Exercise / conversion · Disposed 73,902 · Balance 366,792 F4: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5: The options vested in three annual installments beginning on February 13, 2010.
Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.53 · Expires 2019-02-13	Direct	340,694	Reported balance After 2018-06-12 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2018-06-12 · Exercise / conversion · Disposed 26,098 · Balance 340,694 F4: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5: The options vested in three annual installments beginning on February 13, 2010.
Common StockSEC Table I · non-derivative	IndirectBy 401(k) Plan	1,783.2855	Reported balance Holding disclosure · report date 2018-06-11 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 1,783.2855
Common StockSEC Table I · non-derivative	IndirectBy 401(k) Plan ESOP	4,071.1138	Reported balance Holding disclosure · report date 2018-06-11 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 4,071.1138
Common StockSEC Table I · non-derivative	IndirectBy Trust	799,273.5	Reported balance Holding disclosure · report date 2018-06-11 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 799,273.5

Filing footnotes · ownership attribution and instrument terms

F1: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.60.

F3: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.65.

F4: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights.

F5: The options vested in three annual installments beginning on February 13, 2010.

INTERNATIONAL BUSINESS MACHINES CORP

Report date September 30, 2026 · Filed October 02, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Promised Fee ShareSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	45,262	Reported balance After 2026-09-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-09-30 · Grant · Acquired 444 · Balance 45,262 F1: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.

Filing footnotes · ownership attribution and instrument terms

F1: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash.

F2: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan.

F3: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.

Lucid Group, Inc.

Report date June 04, 2026 · Filed June 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	126,364	Ending reported balance After 2026-06-04 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-06-04 · Grant · Acquired 43,870 · Balance 123,765 F1: These restricted stock units ("RSUs") will vest in full on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of stockholders held after the date of grant, in each case, subject to the reporting person's continued service on the board of directors through the applicable vesting date. The RSUs are also subject to a deferral election by the reporting person and shares will not be issued until the designated deferred settlement date. F2: RSUs are settled in shares of Class A Common Stock on a one-for-one basis. Row 2 · 2026-06-04 · Grant · Acquired 2,599 · Balance 126,364 F3: These RSUs vest in full on the date of the grant in connection with past service. F2: RSUs are settled in shares of Class A Common Stock on a one-for-one basis.
Class A Common StockSEC Table I · non-derivative	IndirectBy Liveris Capital Partners LLC	40,000	Reported balance Holding disclosure · report date 2026-06-04 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 40,000 F4: Interests shown consist of 40,000 shares of Class A Common Stock (the "Liveris Capital Shares") beneficially owned by Liveris Capital Partners LLC ("Liveris Capital"). The reporting person has investment control over Liveris Capital and disclaims beneficial ownership of the Liveris Capital Shares. The Liveris Capital Shares were received as part of a distribution from Churchill Sponsor IV LLC applying equally to all securities of a class in January 2023.

Filing footnotes · ownership attribution and instrument terms

F1: These restricted stock units ("RSUs") will vest in full on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of stockholders held after the date of grant, in each case, subject to the reporting person's continued service on the board of directors through the applicable vesting date. The RSUs are also subject to a deferral election by the reporting person and shares will not be issued until the designated deferred settlement date.

F2: RSUs are settled in shares of Class A Common Stock on a one-for-one basis.

F3: These RSUs vest in full on the date of the grant in connection with past service.

F4: Interests shown consist of 40,000 shares of Class A Common Stock (the "Liveris Capital Shares") beneficially owned by Liveris Capital Partners LLC ("Liveris Capital"). The reporting person has investment control over Liveris Capital and disclaims beneficial ownership of the Liveris Capital Shares. The Liveris Capital Shares were received as part of a distribution from Churchill Sponsor IV LLC applying equally to all securities of a class in January 2023.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

DOW CHEMICAL CO /DE/

Report date August 31, 2017 · Filed September 05, 2017

Section 16 reporting ended · disclosed 2017-09-05. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
CommonSEC Table I · non-derivative	Direct	Reported balance After 2017-08-31 transaction · row 1 1 source row Row 1 · 2017-08-31 · Disposition to issuer · Disposed 215,849.089 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F2: Includes 61,190 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 66,750 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 51,890 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment.
CommonSEC Table I · non-derivative	IndirectBy 401(k) Plan	Reported balance After 2017-08-31 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2017-08-31 · Disposition to issuer · Disposed 1,686.7065 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
CommonSEC Table I · non-derivative	IndirectBy 401(k) Plan ESOP	Reported balance After 2017-08-31 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2017-08-31 · Disposition to issuer · Disposed 3,673.8586 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
CommonSEC Table I · non-derivative	IndirectBy Trust	Reported balance After 2017-08-31 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2017-08-31 · Disposition to issuer · Disposed 821,324.5 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.00 · Expires 2022-02-10	Direct	Reported balance After 2017-08-31 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2017-08-31 · Disposition to issuer · Disposed 516,000 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.19 · Expires 2027-02-10	Direct	Reported balance After 2017-08-31 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2017-08-31 · Disposition to issuer · Disposed 263,860 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F5: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.38 · Expires 2021-02-11	Direct	Reported balance After 2017-08-31 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2017-08-31 · Disposition to issuer · Disposed 412,380 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.79 · Expires 2020-02-12	Direct	Reported balance After 2017-08-31 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2017-08-31 · Disposition to issuer · Disposed 551,800 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.01 · Expires 2026-02-12	Direct	Reported balance After 2017-08-31 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2017-08-31 · Disposition to issuer · Disposed 331,510 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.53 · Expires 2019-02-13	Direct	Reported balance After 2017-08-31 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2017-08-31 · Disposition to issuer · Disposed 909,100 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.44 · Expires 2025-02-13	Direct	Reported balance After 2017-08-31 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2017-08-31 · Disposition to issuer · Disposed 312,670 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F7: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.71 · Expires 2024-02-14	Direct	Reported balance After 2017-08-31 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2017-08-31 · Disposition to issuer · Disposed 315,930 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.62 · Expires 2018-02-15	Direct	Reported balance After 2017-08-31 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2017-08-31 · Disposition to issuer · Disposed 619,370 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.16 · Expires 2023-02-15	Direct	Reported balance After 2017-08-31 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2017-08-31 · Disposition to issuer · Disposed 761,660 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.

F2: Includes 61,190 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 66,750 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 51,890 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment.

F3: This option was fully vested and exercisable at the time of the Merger.

F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option.

F5: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms.

F6: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019.

F7: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 30, 2026 Filed Oct 2, 2026 00:28 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	444	$219.93 Strike: $0.00	$97,648.92	Disclosure SEC source: 0001269971-26-000004 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,262 Underlying: Common Stock · 444 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:06 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	347	$281.21 Strike: $0.00	$97,579.87	Disclosure SEC source: 0001269971-26-000003 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,497 Underlying: Common Stock · 347 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 04, 2026 Filed Jun 8, 2026 20:25 UTC	Lucid Group, Inc. LCID · Entity 1530	GrantClass A Common Stock	2,599	$0.00	$0.00	Disclosure SEC source: 0001628280-26-041595 · wk-form4_1780950331.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,364 F3 · shares: These RSUs vest in full on the date of the grant in connection with past service. F2 · price: RSUs are settled in shares of Class A Common Stock on a one-for-one basis. Read SEC document
June 04, 2026 Filed Jun 8, 2026 20:25 UTC	Lucid Group, Inc. LCID · Entity 1530	GrantClass A Common Stock	43,870	$0.00	$0.00	Disclosure SEC source: 0001628280-26-041595 · wk-form4_1780950331.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,765 F1 · shares: These restricted stock units ("RSUs") will vest in full on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of stockholders held after the date of grant, in each case, subject to the reporting person's continued service on the board of directors through the applicable vesting date. The RSUs are also subject to a deferral election by the reporting person and shares will not be issued until the designated deferred settlement date. F2 · price: RSUs are settled in shares of Class A Common Stock on a one-for-one basis. Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:04 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	403	$242.39 Strike: $0.00	$97,683.17	Disclosure SEC source: 0001269971-26-000002 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,878 Underlying: Common Stock · 403 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
December 31, 2025 Filed Jan 2, 2026 21:03 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	330	$296.21 Strike: $0.00	$97,749.30	Disclosure SEC source: 0001269971-26-000001 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,186 Underlying: Common Stock · 330 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
September 30, 2025 Filed Oct 1, 2025 21:25 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	346	$282.16 Strike: $0.00	$97,627.36	Disclosure SEC source: 0001269971-25-000003 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,628 Underlying: Common Stock · 346 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 30, 2025 Filed Jul 1, 2025 20:07 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	331	$294.78 Strike: $0.00	$97,572.18	Disclosure SEC source: 0001562180-25-005175 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,008 Underlying: Common Stock · 331 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:44 UTC	Lucid Group, Inc. LCID · Entity 1530	GrantClass A Common Stock	4,831	$0.00	$0.00	Disclosure SEC source: 0001628280-25-030245 · wk-form4_1749501801.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 798,930 F3 · shares: These RSUs vest in full on the date of the grant in connection with past service. F2 · price: RSUs are settled in shares of Class A Common Stock on a one-for-one basis. Read SEC document
June 05, 2025 Filed Jun 9, 2025 20:44 UTC	Lucid Group, Inc. LCID · Entity 1530	GrantClass A Common Stock	108,713	$0.00	$0.00	Disclosure SEC source: 0001628280-25-030245 · wk-form4_1749501801.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 794,099 F1 · shares: These restricted stock units ("RSUs") will vest in full on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of stockholders held after the date of grant, in each case, subject to the reporting person's continued service on the board of directors through the applicable vesting date. The RSUs are also subject to a deferral election by the reporting person and shares will not be issued until the designated deferred settlement date. F2 · price: RSUs are settled in shares of Class A Common Stock on a one-for-one basis. Read SEC document
March 31, 2025 Filed Apr 1, 2025 20:45 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	393	$248.66 Strike: $0.00	$97,723.38	Disclosure SEC source: 0001562180-25-002841 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,425 Underlying: Common Stock · 393 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
December 31, 2024 Filed Jan 2, 2025 22:50 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	421	$219.83 Strike: $0.00	$92,548.43	Disclosure SEC source: 0001562180-25-000018 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,768 Underlying: Common Stock · 421 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
September 30, 2024 Filed Oct 1, 2024 22:40 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	419	$221.08 Strike: $0.00	$92,632.52	Disclosure SEC source: 0001562180-24-007079 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,058 Underlying: Common Stock · 419 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 28, 2024 Filed Jul 2, 2024 21:34 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	535	$172.95 Strike: $0.00	$92,528.25	Disclosure SEC source: 0001562180-24-005529 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,320 Underlying: Common Stock · 535 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 04, 2024 Filed Jun 6, 2024 22:33 UTC	Lucid Group, Inc. LCID · Entity 1530	GrantClass A Common Stock	96,822	$0.00	$0.00	Disclosure SEC source: 0000929638-24-002087 · form4.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 685,386 F1 · shares: These restricted stock units ("RSUs") will vest in full on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders held after the date of grant, in each case, subject to the reporting person's continued service on the board of directors through the applicable vesting date. The RSUs are also subject to a deferral election by the reporting person and shares will not be issued until the designated deferred settlement date. F2 · price: RSUs are settled in shares of Class A Common Stock on a one-for-one basis. Read SEC document
March 28, 2024 Filed Apr 1, 2024 21:41 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	485	$190.96 Strike: $0.00	$92,615.60	Disclosure SEC source: 0001562180-24-003109 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,409 Underlying: Common Stock · 485 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
December 29, 2023 Filed Jan 3, 2024 23:40 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	566	$163.55 Strike: $0.00	$92,569.30	Disclosure SEC source: 0001562180-24-000139 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,599 Underlying: Common Stock · 566 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
September 29, 2023 Filed Oct 3, 2023 20:34 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	660	$140.30 Strike: $0.00	$92,598.00	Disclosure SEC source: 0001562180-23-007142 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,661 Underlying: Common Stock · 660 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 30, 2023 Filed Jul 5, 2023 20:36 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	692	$133.81 Strike: $0.00	$92,596.52	Disclosure SEC source: 0001562180-23-005698 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,604 Underlying: Common Stock · 692 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
April 24, 2023 Filed Apr 27, 2023 01:58 UTC	Lucid Group, Inc. LCID · Entity 1530	GrantClass A Common Stock	32,258	Not disclosed	Not disclosed	Disclosure SEC source: 0000950103-23-006277 · dp192695_4-liveris.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 588,564 F1 · shares: These restricted stock units ("RSUs") will vest in full on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders held after the date of grant, in each case, subject to the reporting person's continued service on the board of directors through the applicable vesting date. The RSUs are also subject to a deferral election by the reporting person and shares will not be issued until the designated deferred settlement date. F1 · price: These restricted stock units ("RSUs") will vest in full on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders held after the date of grant, in each case, subject to the reporting person's continued service on the board of directors through the applicable vesting date. The RSUs are also subject to a deferral election by the reporting person and shares will not be issued until the designated deferred settlement date. Read SEC document
March 31, 2023 Filed Apr 3, 2023 20:37 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	706	$131.09 Strike: $0.00	$92,549.54	Disclosure SEC source: 0001562180-23-003242 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,493 Underlying: Common Stock · 706 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
December 31, 2022 Filed Jan 3, 2023 21:22 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	613	$140.89 Strike: $0.00	$86,365.57	Disclosure SEC source: 0001562180-23-000022 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,348 Underlying: Common Stock · 613 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
September 30, 2022 Filed Oct 3, 2022 21:10 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	726	$118.81 Strike: $0.00	$86,256.06	Disclosure SEC source: 0001562180-22-006915 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,378 Underlying: Common Stock · 726 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 30, 2022 Filed Jul 1, 2022 20:31 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	611	$141.19 Strike: $0.00	$86,267.09	Disclosure SEC source: 0001562180-22-005451 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,257 Underlying: Common Stock · 611 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 09, 2022 Filed Jun 13, 2022 20:55 UTC	Lucid Group, Inc. LCID · Entity 1530	GrantClass A Common Stock	9,825	Not disclosed	Not disclosed	Disclosure SEC source: 0000950103-22-010472 · dp175048_4-liveris.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,306 F1 · shares: These restricted stock units ("RSUs") will vest in full on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders held after the date of grant, in each case, subject to the reporting person's continued service on the board of directors through the applicable vesting date. The RSUs are also subject to a deferral election by the reporting person and shares will not be issued until the designated deferred settlement date. F1 · price: These restricted stock units ("RSUs") will vest in full on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders held after the date of grant, in each case, subject to the reporting person's continued service on the board of directors through the applicable vesting date. The RSUs are also subject to a deferral election by the reporting person and shares will not be issued until the designated deferred settlement date. Read SEC document
March 31, 2022 Filed Apr 1, 2022 21:03 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	638	$130.02 Strike: $0.00	$82,952.76	Disclosure SEC source: 0001562180-22-003074 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,280 Underlying: Common Stock · 638 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
December 31, 2021 Filed Jan 4, 2022 23:07 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	608	$133.66 Strike: $0.00	$81,265.28	Disclosure SEC source: 0001562180-22-000133 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,256 Underlying: Common Stock · 608 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
October 25, 2021 Filed Oct 27, 2021 21:21 UTC	Lucid Group, Inc. LCID · Entity 1530	GrantClass A Common Stock	11,206	Not disclosed	Not disclosed	Disclosure SEC source: 0000950103-21-016694 · dp160557_4-liveris.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546,481 F1 · shares: These restricted stock units will vest in equal annual installments on each of July 23, 2022, July 23, 2023 and July 23, 2024 subject to the reporting person's continued service through each applicable vesting date. F1 · price: These restricted stock units will vest in equal annual installments on each of July 23, 2022, July 23, 2023 and July 23, 2024 subject to the reporting person's continued service through each applicable vesting date. Read SEC document
September 30, 2021 Filed Oct 1, 2021 21:03 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	585	$138.93 Strike: $0.00	$81,274.05	Disclosure SEC source: 0001562180-21-006210 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,005 Underlying: Common Stock · 585 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
July 23, 2021 Filed Jul 27, 2021 21:40 UTC	Lucid Group, Inc. LCID · Entity 1530	GrantClass A Common Stock	535,275	Not disclosed	Not disclosed	Disclosure SEC source: 0000950103-21-011281 · dp155127_4-liveris.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,275 F1 · price: Received in exchange for 202,449 shares of common stock of Atieva, Inc., d/b/a Lucid Motors ("Lucid") in connection with the merger by and among Churchill Capital Corp IV, Atieva, Inc., d/b/a Lucid Motors and Air Merger Sub, Inc. Read SEC document
June 30, 2021 Filed Jul 1, 2021 20:33 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	555	$146.59 Strike: $0.00	$81,357.45	Disclosure SEC source: 0001562180-21-004622 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,108 Underlying: Common Stock · 555 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
March 31, 2021 Filed Apr 1, 2021 21:07 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	610	$133.26 Strike: $0.00	$81,288.60	Disclosure SEC source: 0001562180-21-002517 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,278 Underlying: Common Stock · 610 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
December 31, 2020 Filed Jan 4, 2021 21:57 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	646	$125.88 Strike: $0.00	$81,318.48	Disclosure SEC source: 0001562180-21-000040 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,358 Underlying: Common Stock · 646 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
November 02, 2020 Filed Nov 2, 2020 19:42 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	PurchaseCommon Stock	2,655	$112.92	$299,802.60	Disclosure SEC source: 0001562180-20-006483 · primarydocument.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · trust Disclosed balance after: 2,655 F1 · ownership.direct: The reporting person disclaims beneficial ownership of the securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document
September 30, 2020 Filed Oct 1, 2020 20:15 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	668	$121.67 Strike: $0.00	$81,275.56	Disclosure SEC source: 0001562180-20-006177 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,407 Underlying: Common Stock · 668 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 30, 2020 Filed Jul 1, 2020 23:29 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	673	$120.77 Strike: $0.00	$81,278.21	Disclosure SEC source: 0001562180-20-004754 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,436 Underlying: Common Stock · 673 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
March 31, 2020 Filed Apr 1, 2020 21:11 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	733	$110.93 Strike: $0.00	$81,311.69	Disclosure SEC source: 0001562180-20-002806 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,493 Underlying: Common Stock · 733 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
December 31, 2019 Filed Jan 3, 2020 01:22 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	607	$134.04 Strike: $0.00	$81,362.28	Disclosure SEC source: 0001562180-20-000041 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,495 Underlying: Common Stock · 607 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
September 30, 2019 Filed Oct 1, 2019 20:36 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	559	$145.42 Strike: $0.00	$81,289.78	Disclosure SEC source: 0001562180-19-005000 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,651 Underlying: Common Stock · 559 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 28, 2019 Filed Jul 1, 2019 17:41 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	590	$137.90 Strike: $0.00	$81,361.00	Disclosure SEC source: 0001562180-19-003702 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,881 Underlying: Common Stock · 590 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
March 29, 2019 Filed Apr 2, 2019 20:03 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	576	$141.10 Strike: $0.00	$81,273.60	Disclosure SEC source: 0001562180-19-002116 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,075 Underlying: Common Stock · 576 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
December 31, 2018 Filed Jan 2, 2019 21:06 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	715	$113.67 Strike: $0.00	$81,274.05	Disclosure SEC source: 0001562180-19-000060 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,302 Underlying: Common Stock · 715 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
September 28, 2018 Filed Oct 1, 2018 20:12 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	538	$151.21 Strike: $0.00	$81,350.98	Disclosure SEC source: 0001562180-18-004070 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,375 Underlying: Common Stock · 538 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 29, 2018 Filed Jul 2, 2018 20:05 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	582	$139.70 Strike: $0.00	$81,305.40	Disclosure SEC source: 0001562180-18-003154 · primarydocument.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,668 Underlying: Common Stock · 582 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 12, 2018 Filed Jun 13, 2018 21:38 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative	26,098	$0.00 Strike: $9.53	$0.00	Disclosure SEC source: 0001225208-18-010626 · doc4.xml · derivative · entry 9 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,694 Underlying: Common Stock · 26,098 shares Expires 2019-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5 · derivative.exercise_date: The options vested in three annual installments beginning on February 13, 2010. Read SEC document
June 12, 2018 Filed Jun 13, 2018 21:38 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	SaleCommon Stock	26,098	$69.58	$1,815,898.84	Disclosure SEC source: 0001225208-18-010626 · doc4.xml · nonDerivative · entry 4 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,618.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · price: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.65. Read SEC document
June 12, 2018 Filed Jun 13, 2018 21:38 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Exercise / conversionCommon Stock	26,098	$9.53	$248,713.94	Disclosure SEC source: 0001225208-18-010626 · doc4.xml · nonDerivative · entry 3 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,716.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 11, 2018 Filed Jun 13, 2018 21:38 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative	73,902	$0.00 Strike: $9.53	$0.00	Disclosure SEC source: 0001225208-18-010626 · doc4.xml · derivative · entry 8 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,792 Underlying: Common Stock · 73,902 shares Expires 2019-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5 · derivative.exercise_date: The options vested in three annual installments beginning on February 13, 2010. Read SEC document
June 11, 2018 Filed Jun 13, 2018 21:38 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	SaleCommon Stock	73,902	$69.57	$5,141,066.53	Disclosure SEC source: 0001225208-18-010626 · doc4.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,618.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.60. Read SEC document
June 11, 2018 Filed Jun 13, 2018 21:38 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Exercise / conversionCommon Stock	73,902	$9.53	$704,286.06	Disclosure SEC source: 0001225208-18-010626 · doc4.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,520.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.